Literature DB >> 11533227

Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.

R Hrdlicková1, J Nehyba, H R Bose.   

Abstract

The avian homologue of the interferon regulatory factor 4 (IRF-4) and a novel splice variant lacking exon 6, IRF-4DeltaE6, were isolated and characterized. Chicken IRF-4 is expressed in lymphoid organs, less in small intestine, and lungs. IRF-4DeltaE6 mRNA, though less abundant than full-length IRF-4, was detected in lymphoid tissues, with the highest levels observed in thymic cells. IRF-4 is highly expressed in v-Rel-transformed lymphocytes, and the expression of IRF-4 is increased in v-Rel- and c-Rel-transformed fibroblasts relative to control cells. The expression of IRF-4 from retrovirus vectors morphologically transformed primary fibroblasts, increased their saturation density, proliferation, and life span, and promoted their growth in soft agar. IRF-4 and v-Rel cooperated synergistically to transform fibroblasts. The expression of IRF-4 antisense RNA eliminated formation of soft agar colonies by v-Rel and reduced the proliferation of v-Rel-transformed cells. v-Rel-transformed fibroblasts produced interferon 1 (IFN1), which inhibits fibroblast proliferation. Infection of fibroblasts with retroviruses expressing v-Rel resulted in an increase in the mRNA levels of IFN1, the IFN receptor, STAT1, JAK1, and 2',5'-oligo(A) synthetase. The exogenous expression of IRF-4 in v-Rel-transformed fibroblasts decreased the production of IFN1 and suppressed the expression of several genes in the IFN transduction pathway. These results suggest that induction of IRF-4 expression by v-Rel likely facilitates transformation of fibroblasts by decreasing the induction of this antiproliferative pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533227      PMCID: PMC99785          DOI: 10.1128/MCB.21.19.6369-6386.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  111 in total

Review 1.  The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

Authors:  P A Baeuerle
Journal:  Biochim Biophys Acta       Date:  1991-04-16

Review 2.  The interferons. Mechanisms of action and clinical applications.

Authors:  S Baron; S K Tyring; W R Fleischmann; D H Coppenhaver; D W Niesel; G R Klimpel; G J Stanton; T K Hughes
Journal:  JAMA       Date:  1991-09-11       Impact factor: 56.272

3.  A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.

Authors:  G Mosialos; P Hamer; A J Capobianco; R A Laursen; T D Gilmore
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  Activation of the c-ski oncogene by overexpression.

Authors:  C Colmenares; P Sutrave; S H Hughes; E Stavnezer
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Promoter structures and differential responses to viral and nonviral inducers of chicken type I interferon genes.

Authors:  C Sick; U Schultz; U Münster; J Meier; B Kaspers; P Staeheli
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

6.  Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb.

Authors:  Y Kanegae; A T Tavares; J C Izpisúa Belmonte; I M Verma
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

7.  Retroviruses that express different ras mutants cause different types of tumors in chickens.

Authors:  I Givol; J J Greenhouse; S H Hughes; D L Ewert
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

8.  Two types of chicken 2',5'-oligoadenylate synthetase mRNA derived from alleles at a single locus.

Authors:  A Yamamoto; A Iwata; Y Koh; S Kawai; S Murayama; K Hamada; S Maekawa; S Ueda; Y Sokawa
Journal:  Biochim Biophys Acta       Date:  1998-01-21

9.  Expression of v-rel in a replication competent virus: transformation and biochemical characterization.

Authors:  L E Morrison; G Boehmelt; H Beug; P J Enrietto
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

10.  Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene.

Authors:  H Okuno; T Suzuki; T Yoshida; Y Hashimoto; T Curran; H Iba
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

View more
  17 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

3.  Characterization of ATF2 in Rel/NFκB oncogenesis reveals its role in the regulation of Ras signaling.

Authors:  Andrew S Liss; Henry R Bose
Journal:  Small GTPases       Date:  2011-03

4.  Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

Authors:  Jarmila Kralova; Andrew S Liss; William Bargmann; Cullen Pendleton; Janani Varadarajan; Emin Ulug; Henry R Bose
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.

Authors:  Seung-Hee Jo; Jonathan H Schatz; Jaime Acquaviva; Harinder Singh; Ruibao Ren
Journal:  Blood       Date:  2010-06-28       Impact factor: 22.113

6.  Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.

Authors:  Juan Carlos Ramos; Phillip Ruiz; Lee Ratner; Isildinha M Reis; Carlos Brites; Celia Pedroso; Gerald E Byrne; Ngoc L Toomey; Valentine Andela; Edward W Harhaj; Izidore S Lossos; William J Harrington
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

8.  Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

9.  Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins.

Authors:  Nupur Gupta; Jeffrey Delrow; Amar Drawid; Anirvan M Sengupta; Gaofeng Fan; Céline Gélinas
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

10.  Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis.

Authors:  A S Liss; R Tiwari; J Kralova; H R Bose
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.